Thyroid cancer patients receiving an interdisciplinary team ‐based care approach (ITCA‐ThyCa) appear to display better outcomes: Program evaluation results indicating a need for further integrated care and support

Psycho-Oncology,Volume 27, Issue 3, Page 937-945, March 2018.
Source: Psycho-Oncology - Category: Cancer & Oncology Source Type: research

Related Links:

Conclusion: A performance improvement initiative that used the PDSA framework effectively influenced physician adherence to national guidelines for thyroid neoplasms. PMID: 30326028 [PubMed - as supplied by publisher]
Source: Journal of the American Osteopathic Association - Category: Complementary Medicine Tags: J Am Osteopath Assoc Source Type: research
John Kapetaneas is a journalist and segment producer for ABC News "Nightline."
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
This study assessed tumor suppressor roles of CREBBP in SCLC and other neuroendocrine tumors. Genetically engineered mouse models were used to determine the tumor suppressor role of Crebbp in SCLC and other neuroendocrine tumors.  
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
Papillary thyroid cancer has an excellent prognosis, but the appropriate level of treatment is controversial. We compared survival between total thyroidectomy and less-than-total thyroidectomy, and examined the proportion of patients with papillary thyroid cancer in Korea undergoing total thyroidectomy.
Source: Surgery - Category: Surgery Authors: Source Type: research
A new study inCancer Management and Research found a correlation between the age of patients with papillary thyroid cancer and lymph node positivity.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0296-2Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Though previous research showed the MEK1/2 inhibitor could improve RAI effect, the phase 3 trial failed to reach its primary endpoint.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
CONCLUSIONS: This case emphasizes that special consideration should be given to patients with VKA treatment planned to receive immunotherapy. PMID: 30318433 [PubMed - as supplied by publisher]
Source: Revue des Maladies Respiratoires - Category: Respiratory Medicine Tags: Rev Mal Respir Source Type: research
CONCLUSIONS: The presented data and comparison with other commercially available tests suggest that the mir-THYpe test can be considered for use in clinical practice to support a more informed clinical decision for patients with indeterminate thyroid nodules and potentially reduce the rates of unnecessary thyroid surgeries. PMID: 30319072 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
Conclusion Upon to this study, red marrow dose varies with type of preparation as that of medication withdrawal cases was slightly higher than exogenous thyroid-stimulating hormone. Involvement of lesion and red marrow dose assessment through dosimetry protocol seems indeed valuable to optimize safe and effective activity compared with the conventional regime with 250 mCi as maximum empirical activity.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: ORIGINAL ARTICLES Source Type: research
More News: Cancer | Cancer & Oncology | Thyroid | Thyroid Cancer